JD BioWorks Research Resources
Research Library
Source-conscious guides to analytical methods, documentation, compound literature, regulatory developments, and evidence interpretation.
Latest Research
Cagrilintide and Semaglutide: Why Researchers Combined Amylin and GLP-1
CagriSema combines the amylin analogue cagrilintide with the GLP-1 agonist semaglutide. Here is why researchers paired them, what human trials found, and what the evidence does not establish.
Read the latest analysis
Browse articles by month, topic, or compound
Recent Research
31 articles
FDA Generic Peptide Guidance 2026: What Changed?
An overview of FDA's July 2026 revised draft peptide guidances and what they mean for generic drug development.
Read article
FDA Peptide Compounding Vote: What It Actually Means
A guide to the July 2026 peptide-compounding advisory votes and the difference between committee recommendations and FDA approval.
Read articleSelank Research Evidence: What Has Actually Been Studied?
A source-based review of published Selank evidence across human, animal, and molecular research, with study limitations and verified PubMed references.
Read articleTesamorelin research evidence: what has actually been studied?
A neutral evidence review of tesamorelin covering controlled human trials, metabolic studies, safety context, and research limitations.
Read articleTB-500 research evidence: what has actually been studied?
A neutral evidence review of TB-500, emphasizing the distinction from full-length thymosin beta-4 and the limits of available data.
Read articlePT-141 (bremelanotide) research evidence: what has actually been studied?
A neutral evidence review of PT-141 (bremelanotide) covering controlled human trials, safety findings, pharmacology, and limitations.
Read articleNAD+ research evidence: what has actually been studied?
A neutral evidence review of direct NAD+ research, cellular biology, human infusion studies, precursor distinctions, and limitations.
Read articleMOTS-C research evidence: what has actually been studied?
A neutral evidence review of MOTS-C discovery, cell and animal studies, limited human evidence, and research limitations.
Read articleKPV research evidence: what has actually been studied?
A neutral evidence review of KPV covering cell studies, mouse colitis models, human evidence gaps, and primary references.
Read articleRESEARCH RESOURCE PATHWAY
Compound research evidence library
Browse research-only literature overviews organized by exact compound name. Each page separates reported findings from analytical identity and evidence limitations.
BPC-157 research evidence
A source-conscious overview of preclinical evidence and study limitations.
GHK-Cu research evidence
Research context for GHK-Cu, terminology, methods, and study limitations.
KPV research evidence
Research context, sequence identity, documentation, and evidence limitations.
MOTS-C research evidence
Research context for a mitochondrial-derived peptide and its documentation needs.
PT-141 research evidence
A research-only review of nomenclature, identity, literature, and limitations.
Selank research evidence
Research context, peptide identity, sourcing records, and evidence limits.
TB-500 research evidence
Clarify nomenclature, sequence claims, laboratory identity, and source limitations.
Tesamorelin research evidence
Research context, identity documentation, analytical methods, and evidence limits.
RESEARCH RESOURCE PATHWAY
Research and editorial standards
See how sources, corrections, and document revisions are handled.
Scientific sourcing and editorial standards
How JD BioWorks selects sources, distinguishes evidence levels, and updates research content.
Corrections and document revision policy
How factual corrections, material updates, and superseded records are handled.
START WITH THE RESEARCH QUESTION